Amsterdam, Netherlands

Johannes Langedijk




Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Amsterdam, NL (2019)
  • Leiden, NL (2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Johannes Langedijk

Introduction

Johannes Langedijk is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and viral glycoproteins. With a total of three patents to his name, Langedijk's work has the potential to impact public health positively.

Latest Patents

One of Langedijk's latest patents is focused on Stabilized Filovirus glycoprotein trimers. This invention provides mutations in the Filovirus glycoproteins that stabilize their trimeric form. The glycoproteins exhibit improved trimer formation and yield compared to those without the specified amino acid substitutions. Additionally, he has developed a vaccine against Respiratory Syncytial Virus (RSV). This patent describes compositions that include a recombinant RSV Fusion (F) polypeptide, which is stabilized in its pre-fusion conformation. The polypeptide includes specific mutations that enhance its stability and efficacy.

Career Highlights

Langedijk is currently associated with Janssen Vaccines & Prevention B.V., where he continues to innovate in the field of vaccine development. His work is crucial in addressing viral infections and improving vaccine formulations.

Collaborations

He collaborates with esteemed colleagues such as Dirk André Emmy Roymans and Polina Furmanova Hollenstein. Their combined expertise contributes to the advancement of their research and the development of effective medical solutions.

Conclusion

Johannes Langedijk's contributions to biotechnology and vaccine development are noteworthy. His innovative patents and collaborations reflect his commitment to improving public health through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…